Elisa Granato (Coronavirus Vaccine Trail) Wiki/Bio, Age, Husband, Family

Elisa Granato is a British scientist, microbiologist and cancer researcher who gained worldwide popularity after become volunteer for Coronavirus vaccine trail developed by Sarah Gilbert. She mainly research on Microbial Ecology, Social Evolution and Infectious Diseases.

Quick Facts
April 23, 1988
Age 36 years
Birth place United Kingdom
Education  University of Oxford
Research interests Microbial Ecology, Social Evolution, Infectious Diseases
Occupation Microbiologist

Early life

Elisa Granato was born in April 23, 1987 in United Kingdom.


Elisa Granato finished her early schooling in her hometown and studied in collage, later she started studying in  University of Oxford where she became a researcher.

Personal Life

Elisa Granato‘s marital or relationship status not published in any news/sources.


Elisa Granato first started researching on simple topics and later she became one of top cancer researcher.

Coronavirus vaccine trail

Two volunteers were injected, the first of more than 800 people recruited into the study.

Half receive the Covid-19 vaccine and the other half receive a control vaccine that protects against meningitis but not against coronavirus.

The design of the trial means that volunteers do not know which vaccine they will receive, but doctors do.

Elisa Granato, one of the two who received the shot, told the BBC, “I’m a scientist, so I

wanted to try to support the scientific process whenever possible.”

The vaccine was developed in less than three months by a team from the University of Oxford. Sarah Gilbert, professor of vaccination at the Jenner Institute, led the preclinical study.

“I personally have a lot of confidence in this vaccine,” she said.

“Of course we need to get human testing and data. We need to demonstrate that it really works and prevents people from becoming infected with coronavirus before using the vaccine in the wider population.”

Prof Gilbert previously said she was “80% sure” that the vaccine would work, but now prefers not to rate it, because she is simply “very optimistic” about the odds. (Source: BBC)